CARsgen Therapeutics Holdings Limited (2171.HK) Financials

2171.HK Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 1.4 billion 570.7 million
June 30, 2025 1.7 billion 604.0 million
Dec. 31, 2024 1.8 billion 655.8 million
June 30, 2024 2.3 billion 650.3 million

2171.HK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 ? ?
June 30, 2025 -228.7 million ?
Dec. 31, 2024 -158.7 million -107463
June 30, 2024 -280.0 million 9.9 million

2171.HK Net Income

No data available :(

2171.HK Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 1.3 billion 53.8 million 53.8 million
June 30, 2025 1.4 billion 78.5 million 75.9 million
Dec. 31, 2024 1.6 billion 73.3 million 82.2 million
June 30, 2024 1.8 billion 117.3 million 90.2 million

2171.HK Shares Outstanding

No data available :(

2171.HK Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 52.8 million 125.9 million 32.7 million -
June 30, 2025 2.4 million 141.3 million 46.1 million -
Dec. 31, 2024 4.9 million 248.0 million 27.7 million 465499
June 30, 2024 5.0 million 250.5 million 28.0 million 470134

2171.HK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 81.7 million 26.4 million
June 30, 2025 60.0 million 38.3 million
Dec. 31, 2024 21.0 million 13.1 million
June 30, 2024 21.2 million 13.3 million

2171.HK

Price: HK$15.02

52 week price:
9.90
26.58

Earnings Per Share: -1.07 HKD

P/E Ratio: -11.19

Exchange: HKG

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 6.6 billion

Links: